| Peer-Reviewed

Large Scale Process to Prepare Highly Pure Bosentan Monohydrate

Received: 28 August 2014     Accepted: 15 September 2014     Published: 23 September 2014
Views:       Downloads:
Abstract

Described is an improved process for the preparation of highly pure Bosentan monohydrate (>99.8% HPLC purity) 1 with pyrimidinone 8 and the dimer 9 impurities to less than 0.10% of HPLC analysis. The present work also provides processes for the preparation of pyrimidinone 8 and dimer 9 impurities.

Published in Science Journal of Chemistry (Volume 2, Issue 6-1)

This article belongs to the Special Issue Green Chemistry: Synthesis and Its Uses

DOI 10.11648/j.sjc.s.2014020601.12
Page(s) 9-15
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2014. Published by Science Publishing Group

Keywords

Bosentan monohydrate, highly pure, Pulmonary artery hypertension

References
[1] (a) M. Hoeper, N. Taha, A. Bekjarova, R. Gatzke, E. Spiekerkoetter, “Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids,” Eup. Respir. J.2003, 22, 330. (b) J.M. Pearl, S.A. wellmann, J.L, Mcnamara, J.P. Lombardi, C.J. Wager, J.L. Raake, D.P. Nelson,’ Bosentan prevents hypoxia-reoxygenation-induced pulmonary hypertension and improves pulmonary function,” Ann Thorac. Surg. 1999, 68, 1714 (c) W.K. Kenneth, M.N. Jean, “Bosentan for the treatment of pulmonary arterial hypertension,” Ann Pharmacother 2003 Jul-Aug; 37 (7-8):1055-62
[2] B. Kaspar, C. Martin, F. Walter, H. Georges, L. Bernd-Michael, N. Werner, R. Henri, “Sulfonamides,” U.S. Patent 5,292,740, 1994.
[3] (a) P.J. Harrington, H.N. Khatri, B.S. Dehoff, “Preparation of sulfonamides.” U.S. Patent 6,136,971, 2000. (b) P.J. Harrington, H.N. Khatri, B.S. Dehoff, M.R. Guinin, M.A. Boehler, K.A. Glaser, “Research and development of a second-generation process for bosentan, an endothelin receptor antagonist,” Org. Process Res. Dev. 2002, 6, 120
[4] (a) C.N. Navnath, M.J. Kunal T.G. Chandrashekhar, N.J. Madhukar, T.M. Vijayavittal, “Facile one-pot process for large-scale production of highly pure bosentan monohydrate, an endothelin receptor antagonist,” Org. Process Res. Dev. 2011, 15, 1382 (b), C.N.Navkanth, M.J. Kunal, T.G. Chandrashekhar, N.J. Madhukar, T.M. Vijayavittal, “ A novel process for preparation of Bosentan,” WO2012/020421
[5] (a) B. Volker, B. Kaspar, C. Jean-Marie, C. Martine, H. Georges, L. Bernd-Michael, M. Marcel, N. Werner, R. Henri, “Sulfonylaminopyrimidines,” U.S.Patent 5,541,186, 1996.(b) A. Gaitonde, B. Manojkumar, S. Mekde, V. Padalkar, H. Mande, .”Process for preparing Bosentan,” WO2009/098517, 2009 (c)M. Satyanarayanareddy, S. Eswaraiah, G. Venkatreddy, “Improved and novel process for the preparation of Bosentan,” WO2009/095933 (d) K. Sata, B. Pandey, “Process for preparation of Bosentan,” WO/2010/032261(e) D. Rao, K. Ramachandra N.P. Rajendra, S.S. Manjinder, A. Ashwini, “Method of synthesis of Bosentan, its polymorphic forms and its salts,” WO2009/083739 (g) G. Biffi, L. Feliciani, E. Viscardi, “Process for the preparation of Bosentan,” WO2010/103362, (h) G. Dixit, N. Gaikwad, H. ;Naidu, P. Prasad S. Nitin, J. Valgeirsson, “Process for the preparation of Bosentan and related compounds,” WO2009/112954(i) J.V. Raman, S. Patel, S. Mistry, B. Parmar, M. Timbadiya, M. Madam, “An improved process for preparing Bosentan,” WO2012/073135 (j) B. Giancarlo, F. Lazzaro, V. Enrico, “Process for the preparation of Bosentan’” U.S. Patent 2012/0041200 (k) T. Maurizio, N. Diletta, A. Pietro, R. Gabriele, M. Simone, “Process for the preparation of Bosentan” U.S. Patent 2009/0156811(l) V. Gore, M. Bindu, D. Shinde, D. Kokane, S. Ghrat, R.Dandala, “Process for the preparation of Bosentan,” WO2012/056468.
[6] K. Amala, K. Srinivasu, B. VeeraSwamy, K. Subash, AKS. Bhujanga Rao, N. VenkaiahChowdary, “Process for the preparation of B osentan monohydrate,” US2013/245259.
Cite This Article
  • APA Style

    Amala Kompella, Srinivasu Kasa, Veera Swami Balina, Subhash Kusumba, Bhujanga Rao Kalisatya Adibhatla, et al. (2014). Large Scale Process to Prepare Highly Pure Bosentan Monohydrate. Science Journal of Chemistry, 2(6-1), 9-15. https://doi.org/10.11648/j.sjc.s.2014020601.12

    Copy | Download

    ACS Style

    Amala Kompella; Srinivasu Kasa; Veera Swami Balina; Subhash Kusumba; Bhujanga Rao Kalisatya Adibhatla, et al. Large Scale Process to Prepare Highly Pure Bosentan Monohydrate. Sci. J. Chem. 2014, 2(6-1), 9-15. doi: 10.11648/j.sjc.s.2014020601.12

    Copy | Download

    AMA Style

    Amala Kompella, Srinivasu Kasa, Veera Swami Balina, Subhash Kusumba, Bhujanga Rao Kalisatya Adibhatla, et al. Large Scale Process to Prepare Highly Pure Bosentan Monohydrate. Sci J Chem. 2014;2(6-1):9-15. doi: 10.11648/j.sjc.s.2014020601.12

    Copy | Download

  • @article{10.11648/j.sjc.s.2014020601.12,
      author = {Amala Kompella and Srinivasu Kasa and Veera Swami Balina and Subhash Kusumba and Bhujanga Rao Kalisatya Adibhatla and Pulla Reddy Muddasani},
      title = {Large Scale Process to Prepare Highly Pure Bosentan Monohydrate},
      journal = {Science Journal of Chemistry},
      volume = {2},
      number = {6-1},
      pages = {9-15},
      doi = {10.11648/j.sjc.s.2014020601.12},
      url = {https://doi.org/10.11648/j.sjc.s.2014020601.12},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.sjc.s.2014020601.12},
      abstract = {Described is an improved process for the preparation of highly pure Bosentan monohydrate (>99.8% HPLC purity) 1 with pyrimidinone 8 and the dimer 9 impurities to less than 0.10% of HPLC analysis. The present work also provides processes for the preparation of pyrimidinone 8 and dimer 9 impurities.},
     year = {2014}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Large Scale Process to Prepare Highly Pure Bosentan Monohydrate
    AU  - Amala Kompella
    AU  - Srinivasu Kasa
    AU  - Veera Swami Balina
    AU  - Subhash Kusumba
    AU  - Bhujanga Rao Kalisatya Adibhatla
    AU  - Pulla Reddy Muddasani
    Y1  - 2014/09/23
    PY  - 2014
    N1  - https://doi.org/10.11648/j.sjc.s.2014020601.12
    DO  - 10.11648/j.sjc.s.2014020601.12
    T2  - Science Journal of Chemistry
    JF  - Science Journal of Chemistry
    JO  - Science Journal of Chemistry
    SP  - 9
    EP  - 15
    PB  - Science Publishing Group
    SN  - 2330-099X
    UR  - https://doi.org/10.11648/j.sjc.s.2014020601.12
    AB  - Described is an improved process for the preparation of highly pure Bosentan monohydrate (>99.8% HPLC purity) 1 with pyrimidinone 8 and the dimer 9 impurities to less than 0.10% of HPLC analysis. The present work also provides processes for the preparation of pyrimidinone 8 and dimer 9 impurities.
    VL  - 2
    IS  - 6-1
    ER  - 

    Copy | Download

Author Information
  • Natco Research Centre, B-13, Industrial Estate, Sanath Nagar, Hyderabad, India

  • Natco Research Centre, B-13, Industrial Estate, Sanath Nagar, Hyderabad, India

  • Natco Research Centre, B-13, Industrial Estate, Sanath Nagar, Hyderabad, India

  • Natco Research Centre, B-13, Industrial Estate, Sanath Nagar, Hyderabad, India

  • Natco Research Centre, B-13, Industrial Estate, Sanath Nagar, Hyderabad, India

  • Natco Research Centre, B-13, Industrial Estate, Sanath Nagar, Hyderabad, India

  • Sections